Literature DB >> 15041089

Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: preliminary findings.

Maurice Corcos1, Olivier Guilbaud, Sabrina Paterniti, Florence Curt, Linnea Hjalmarsson, Marlène Moussa, Jean Chambry, Gwenolé Loas, Gérard Chaouat, Philippe Jeammet.   

Abstract

OBJECTIVE: Some studies suggest that inaccuracy in recognizing and describing emotional states, combined with a highly descriptive mode of expression, as in alexithymia, may influence the immune response. We therefore investigated in healthy women the relationship between alexithymia and circulating levels of IL-1, IL-2 and IL-4.
METHOD: Seventeen mentally and physically healthy women aged between 20 and 25 years completed psychological questionnaires to assess alexithymia (Toronto Alexithymia Scale: TAS) and depressed mood (Hospital Anxiety and Depression Scale: HAD). Serum concentrations of IL-1, IL-2 and IL-4 were measured by ELISA.
RESULTS: We found a significant positive correlation between serum levels of IL-4 and TAS score (r = 0.55; p = 0.021) and between factor 1 of the TAS (difficulty in identifying feelings) and IL-4 (r = 0.57; p = 0.017) while serum IL-1 and IL-2 were not detected in ten and six patients, respectively. Although there was a significant correlation between age and IL-4 levels, a linear regression with BMI, age, depressed mood and TAS as independent variables showed that only alexithymia could predict significantly increased levels of IL-4.
CONCLUSION: Alexithymia and difficulty in identifying feelings could be associated with increased levels of IL-4 which may result in chronic impairment of pro/anti-inflammatory cytokine balance with psychological and somatic consequences. Nevertheless, these intriguing findings would deserve replication and extension in a larger sample of subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15041089     DOI: 10.1016/S0306-4530(03)00087-8

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  5 in total

1.  Psychological Distress Mediates the Effect of Alexithymia on 2-Year Change in HIV Viral Load.

Authors:  Roger C McIntosh; Gail Ironson; Michael Antoni; Betty Lai; Mahendra Kumar; Mary Ann Fletcher; Neil Schneiderman
Journal:  Int J Behav Med       Date:  2017-04

2.  Alexithymia and acne vulgaris: a case control study.

Authors:  Didem Sunay; Murat Baykir; Gülfem Ateş; Meral Ekşioğlu
Journal:  Psychiatry Investig       Date:  2011-11-03       Impact factor: 2.505

3.  Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab.

Authors:  John D Davis; Ashish Bansal; David Hassman; Bolanle Akinlade; Meng Li; Zhaoyang Li; Brian Swanson; Jennifer D Hamilton; A Thomas DiCioccio
Journal:  Clin Pharmacol Ther       Date:  2018-04-02       Impact factor: 6.875

4.  Decreased Immune Response in Alexithymic Women: A One-Year Longitudinal Study.

Authors:  Olivier Guilbaud; Claire Perrin; Florence Curt; Gérard Chaouat; Corinne Dugré-Le Bigre; Martine Strebler; Catherine Touitou; Maurice Corcos
Journal:  Front Psychiatry       Date:  2021-12-20       Impact factor: 4.157

5.  Unique cytokine signature in the plasma of patients with fibromyalgia.

Authors:  Jamie Sturgill; Elizabeth McGee; Victoria Menzies
Journal:  J Immunol Res       Date:  2014-03-11       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.